Tryton Medical Closes $20 Million Series D Funding Round
Tryton Medical Inc., a Durham, N.C.-based developer of stents designed to treat bifurcation lesions, closed a $20 million Series D round of financing. Current investors PTV Sciences, RiverVest Venture Partners and Spray Venture Partners participated in the round. The financing was lead by Arnerich Massena. Arnerich Massena’s Russell J. Rottiers joined Tryton as a director.
14 September 2010•3 mins read
